Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT

Severe combined immunodeficiency (SCID) is effectively treated with hematopoietic cell transplantation (HCT), with overall survival approaching 90% in contemporary reports. However, survivors are at risk for developing late complications because of the variable durability of high-quality immune func...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Heimall, Jennifer, Buckley, Rebecca H., Puck, Jennifer, Fleisher, Thomas A., Gennery, Andrew R., Haddad, Elie, Neven, Benedicte, Slatter, Mary, Roderick, Skinner, Baker, K. Scott, Dietz, Andrew C., Duncan, Christine, Griffith, Linda M., Notarangelo, Luigi, Pulsipher, Michael A., Cowan, Morton J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015789/
https://ncbi.nlm.nih.gov/pubmed/28479164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.026
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller